Prostat kanseri genellikle belirti vermeden ilerlediği için rutin kontroller büyük önem taşır. Üroloji Uzmanı Doç. Dr. Umut Ünal, prostat kanseri hakkında yaş, idrar şikayetleri, PSA değerleri, tedavi gerekliliği ve cinsel yaşam üzerindeki etkileri gibi konularda doğru bilinen yanlışları açıkladı.
Dermot Murnaghan, a veteran TV presenter known for his work on BBC, ITV, and Sky News, has died at the age of 68. He passed away peacefully at home in North London, a year after revealing his stage four prostate cancer diagnosis. Murnaghan was an advocate for men's health, urging them to get tested for prostate cancer.
Dermot Murnaghan, a veteran BBC and Sky News presenter known for hosting "Eggheads", has died at the age of 68. His family announced his passing, stating he died peacefully at home in north London after a period of illness with prostate cancer. Murnaghan publicly shared his stage four prostate cancer diagnosis last year.
Dermot Murnaghan, a veteran TV presenter known for his work on BBC, ITV, and Sky News, has died at the age of 68. He had been diagnosed with stage four prostate cancer a year ago and was an advocate for early testing.
Godartad prostataförstoring drabbar hälften av män över 50 och kan leda till njurproblem, sömnsvårigheter och social isolering. En ny patientförening, Manlig hälsa, kämpar för bättre vård och behandling.
Prostat kanseri tedavisi hakkında yaygın yanlış inanışlar ve modern tedavi yöntemleri.
Hong Kong researchers are developing an affordable blood test for prostate cancer, aiming to reduce the need for invasive biopsies. The technology is expected to launch in about two years, offering a less uncomfortable diagnostic process for patients like Peter Wan, who experienced a lengthy and invasive journey to his diagnosis.
Jeremy Clarkson announced he is in remission from prostate cancer, days after revealing his diagnosis. The TV presenter shared on Clarkson's Farm that he had an aggressive form diagnosed in 2025, but follow-up tests confirmed he is cancer-free.
Jeremy Clarkson ha annunciato di avere un cancro alla prostata aggressivo ma diagnosticato precocemente durante la quinta stagione di "Clarkson's Farm". La notizia ha commosso il pubblico e il co-protagonista Kaleb Cooper, mentre personaggi come Rishi Sunak e Piers Morgan hanno lanciato appelli alla prevenzione.
Jeremy Clarkson, the renowned British presenter, has revealed he has been diagnosed with aggressive but early-stage prostate cancer. He announced the news during the latest episode of his Amazon Prime Video series, 'Clarkson's Farm,' stating he has known since May and underwent surgery, with the outcome still uncertain.
Jeremy Clarkson, 66 anni, ha annunciato di avere un cancro aggressivo alla prostata, individuato nelle fasi iniziali. Si aspetta di stare 'bene' dopo il trattamento.
A large-scale study from Harvard University suggests that men ejaculating over 21 times per month may have a 19-22% lower risk of developing low-risk prostate cancer. However, frequent ejaculation showed no significant protective effect against high-risk or metastatic prostate cancer. Urologist Huang Po-jen emphasizes that this is an observational study showing correlation, not causation, and advises against deliberately altering ejaculation frequency for cancer prevention. He recommends a healthy lifestyle and regular screenings as the primary methods for prostate cancer prevention.
Prostat kanseri yaşlanan nüfus ve gelişen tanı yöntemleriyle artıyor, 50 yaş sonrası kontrol öneriliyor. Mesane kanserinde en büyük risk sigara ve belirtisi ağrısız kanlı idrar. Cilt kanserinde ise güneşten korunma hayati önem taşıyor.
Thousands of men in England diagnosed with low- or intermediate-risk prostate cancer will be offered SABR, a precision radiotherapy that reduces treatment sessions from 20 to five. This advanced technique targets the disease more effectively, minimizing side effects and allowing patients to return to normal life sooner. NHS England expects all 48 radiotherapy centers to offer the treatment within weeks.
UK health secretary backs UKNSC recommendation against population-wide PSA screening, opting for targeted testing of high-risk BRCA2 mutation carriers. Funding is increased for the Transform trial to include more Black men, addressing concerns about health inequalities.
Tens of thousands more black men aged 45-74 in the UK will be invited for prostate cancer checks as part of an £18 million government-funded trial. The move aims to find better testing methods for the disease, which disproportionately affects black men.
Le cancer de la prostate, fréquent et meurtrier chez les hommes, soulève la question de son dépistage systématique. Le test PSA, bien qu'utilisé pour le diagnostic précoce, fait débat en raison de ses faux positifs et de la lenteur d'évolution de nombreux cancers.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
UK's National Screening Committee recommends prostate cancer screening via PSA blood test only for men with BRCA2 gene variant and family history of specific cancers, citing harms outweighing benefits in other groups.
Israeli PM Netanyahu revealed a recent treatment for a malignant prostate tumor, discovered early after a benign enlargement surgery. He has a history of health issues, including a pacemaker implantation in 2023 and hernia surgery in 2024.
Urologist Lin Po-ting suggests men consume 1-2 servings of tofu/dried tofu or 100-150ml of whole soybean milk daily to support prostate health. This intake helps produce Equol, a compound that can interfere with DHT's stimulation of prostate cells and may have anti-inflammatory effects.
A 71-year-old man in Taiwan was diagnosed with stage II prostate cancer and opted for the non-invasive 'HIFU knife' treatment. The procedure, which uses focused ultrasound to destroy cancer cells, resulted in a quick recovery with preserved urinary and sexual function, significantly improving his quality of life.
Eine umfassende Studie zeigt, dass PSA-Bluttests Prostatakrebs-Sterblichkeit senken, aber der Nutzen ist gering. Viele Männer könnten unnötige Behandlungen und Komplikationen riskieren. Eine gemeinsame Entscheidungsfindung wird empfohlen.
A comprehensive review of six trials with nearly 800,000 men shows prostate cancer screening reduces deaths by 2 per 1,000 men screened, but also leads to unnecessary treatments and complications, highlighting the need for informed patient decisions.
